Patents by Inventor Pilar GOYA
Pilar GOYA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10577360Abstract: The present invention relates to arylamide derivatives having dual pharmacological activity towards both the ?2? subunit, in particular the ?2?-1 subunit, of the voltage-gated calcium channel and the ?-opioid receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in particular for the treatment of pain.Type: GrantFiled: April 12, 2017Date of Patent: March 3, 2020Assignee: ESTEVE PHARMACEUTICALS, S.A.Inventors: Pilar Goya, Antoni Torrens-Jover, Carmen Almansa-Rosales, Jose-Luis Diaz-Fernández, Ana-Maria Caamaño-Moure
-
Publication number: 20190127357Abstract: The present invention relates to arylamide derivatives having dual pharmacological activity towards both the ?2? subunit, in particular the ?2?-1 subunit, of the voltage-gated calcium channel and the ?-opioid receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in particular for the treatment of pain.Type: ApplicationFiled: April 12, 2017Publication date: May 2, 2019Inventors: Pilar GOYA, Antoni TORRENS-JOVER, Carmen ALMANSA-ROSALES, Joser-Luis DIAZ-FERNÁNDEZ, Ana-Maria CAAMAÑO-MOURE
-
Publication number: 20160152579Abstract: The present invention relates to a family of differently substituted oxazolidinones and to the pharmaceutically acceptable salts, esters, prodrugs, tautomers, solvates and hydrates thereof, which show affinity for the alpha and gamma subtypes of the peroxisome proliferator-activated receptors (PPAR) and which, therefore, modulate the actions regulated by said receptors, such as inducing satiety, controlling ingestion and modulating metabolic effects, and thus are useful for the administration thereof as a pharmacological tool and as drugs for the treatment and/or prevention of metabolic diseases and cardiovascular diseases.Type: ApplicationFiled: July 11, 2014Publication date: June 2, 2016Applicants: Servicio Andaluz de Salud, Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS), Consejo Superior de Investigaciones Científicas (CSIC)Inventors: Ruth Pérez Fernández, María Nieves Fresno López, José Elguero Bertolini, Pilar Goya Laza, Ana Belén Torres Zaguirre, Fernando Rodíguez De Fonseca, Francisco Javier Pavón Morón, Manuel Macías González, Miguel Romero Cuevas
-
Patent number: 8349878Abstract: The invention relates to the use of compounds having pharmacological activity towards the sigma receptor, and more particularly to 1,2,4-triazole derivatives of formula I to processes of preparation of such compounds and to pharmaceutical compositions comprising them.Type: GrantFiled: September 12, 2011Date of Patent: January 8, 2013Assignee: Laboratorios del Dr. Esteve, S.A.Inventors: Nadine Jagerovic, Jose Maria Cumella-Montanchez, Maria Pilar Goya-Laza, Alberto Dordal Zueras, Maria Rosa Cuberes-Altisent
-
Patent number: 8193223Abstract: The invention relates to compounds having pharmacological activity towards the sigma receptor, and more particularly to 1,2,3-triazole derivatives of formula (I) and to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy and prophylaxis, in particular for the treatment of psychosis or pain.Type: GrantFiled: November 7, 2007Date of Patent: June 5, 2012Assignee: Laboratorios Del Dr. Esteve, S.A.Inventors: Nadine Jagerovic, Cristina Ana Gomez-De La Oliva, Maria Pilar Goya-Laza, Alberto Dordal Zueras, Maria Rosa Cuberes-Altisent
-
Patent number: 8188312Abstract: The present invention is related to acyclic sulfamide derivatives, useful for the manufacture of a medicament for satiety induction and ingestion control, corporal fat modulation and lipidic metabolism regulation and for the manufacture of a medicament for the treatment or prevention of diabetes and cardiovascular diseases. The acyclic sulfamide derivatives are also useful for cosmetic use.Type: GrantFiled: January 26, 2007Date of Patent: May 29, 2012Assignees: Fundacion Imabis. Instituto Mediterraneo para el Avance de la Biotecnologia y la Investigacion Sanitaria, Consejo Superior de Investigaciones CientificasInventors: Fernando Antonio Rodriguez de Fonseca, Manuel Macias Gonzalez, Javier Pavon Moron, María Pilar Goya-Laza, Juan Antonio Paez Prosper, Carolina Cano Ramos
-
Publication number: 20120004211Abstract: The invention relates to the use of compounds having pharmacological activity towards the sigma receptor, and more particularly to 1,2,4-triazole derivatives of formula I to processes of preparation of such compounds and to pharmaceutical compositions comprising them.Type: ApplicationFiled: September 12, 2011Publication date: January 5, 2012Applicant: LABORATORIOS DEL DR. ESTEVE, S.A.Inventors: Nadine Jagerovic, Jose Maria Cumella-Montanchez, Maria Pilar Goya-Laza, Alberto Dordal Zueras, Maria Rosa Cuberes-Altisent
-
Patent number: 8039497Abstract: The invention relates to the use of compounds having pharmacological activity towards the sigma receptor, and more particularly to 1,2,4-triazole derivatives of formula (I) to processes of preparation of such compounds and to pharmaceutical compositions comprising them.Type: GrantFiled: November 7, 2007Date of Patent: October 18, 2011Assignee: Laboratorios Del Dr. Esteve, S.A.Inventors: Nadine Jagerovic, Jose Maria Cumella-Montanchez, Maria Pilar Goya-Laza, Alberto Dordal Zueras, Maria Rosa Cuberes-Altisent
-
Publication number: 20100179224Abstract: The present invention is related to acyclic sulphamide derivatives of formula (I), wherein R1 and R2 may be the same or different, when R1 and R2 are different, R1 is a linear C12-C20 alkyl group or a linear C12-C20 alkenyl group comprising 1, 2, 3 or 4 double bonds; and R2 is a hydrogen atom or a C1-C4 alkyl group, or when R1 and R2 are the same, R1 and R2 are a linear C14-C20 alkyl group or a linear C14-C20 alkenyl group with 1, 2, 3 or 4 double bonds, and pharmaceutically acceptable salts, solvates and hydrates thereof, useful for the manufacture of a medicament for satiety induction and ingestion control, corporal fat modulation and lipidic metabolism regulation and for the manufacture of a medicament for the treatment or prevention of diabetes and cardiovascular diseases. The acyclic sulphamide derivatives are also useful for cosmetic use for reducing subcutaneous fat.Type: ApplicationFiled: January 26, 2007Publication date: July 15, 2010Applicants: Fundacion Imabis. Instituto Mediterraneo Para El Avance De La Biotecnologia y La Investigacion Sanitaria, Consejo Superior De Investigaciones CientificasInventors: Fernando Antonio RODRIGUEZ DE FONSECA, Manuel MACIAS GONZALEZ, Javier PAVON MORON, María Pilar GOYA-LAZA, Juan Antonio PAEZ PROSPER, Carolina CANO RAMOS
-
Publication number: 20100048712Abstract: The present invention is related to acyclic sulphamide derivatives of formula (I), wherein R1 and R2 may be the same or different, when R1 and R2 are different, R1 is a linear C12-C20 alkyl group or a linear C12-C20 alkenyl group comprising 1, 2, 3 or 4 double bonds; and R2 is a hydrogen atom or a C1-C4 alkyl group, or when R1 and R2 are the same, R1 and R2 are a linear C14-C20 alkyl group or a linear C14-C20 alkenyl group with 1, 2, 3 or 4 double bonds, and pharmaceutically acceptable salts, solvates and hydrates thereof, useful for the manufacture of a medicament for satiety induction and ingestion control, corporal fat modulation and lipidic metabolism regulation and for the manufacture of a medicament for the treatment or prevention of diabetes and cardiovascular diseases. The acyclic sulphamide derivatives are also useful for cosmetic use for reducing subcutaneous fat.Type: ApplicationFiled: January 26, 2007Publication date: February 25, 2010Applicants: Fundacion Imabis. Instituto Mediterraneo Para El Avance De La Biotecnologia y La Investigacion Sanitaria, Consejo Superior De Investigaciones CientificasInventors: Fernando Antonio RODRIGUEZ DE FONSECA, Manuel MACIAS GONZALEZ, Javier PAVON MORON, María Pilar GOYA-LAZA, Juan Antonio PAEZ PROSPER, Carolina CANO RAMOS
-
Publication number: 20100004224Abstract: The invention relates to the use of compounds having pharmacological activity towards the sigma receptor, and more particularly to 1,2,4-triazole derivatives of formula (I) to processes of preparation of such compounds and to pharmaceutical compositions comprising them.Type: ApplicationFiled: November 7, 2007Publication date: January 7, 2010Applicant: LABORATORIOS DEL DR. ESTEVE, S.A.Inventors: Nadine Jagerovic, Jose Maria Cumella-Montanchez, Maria Pilar Goya-Laza, Alberto Dordal Zueras, Maria Rosa Cuberes-Altisent
-
Publication number: 20100004265Abstract: The invention relates to compounds having pharmacological activity towards the sigma receptor, and more particularly to 1,2,3-triazole derivatives of formula (I) and to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy and prophylaxis, in particular for the treatment of psychosis or pain.Type: ApplicationFiled: November 7, 2007Publication date: January 7, 2010Inventors: Nadine Jagerovic, Cristina Ana Gomez-De La Oliva, Maria Pilar Goya-Laza, Alberto Dordal Zueras, Maria Rosa Cuberes-Altisent
-
Publication number: 20090221710Abstract: The present invention is related to acyclic sulfamide derivatives, useful for the manufacture of a medicament for satiety induction and ingestion control, corporal fat modulation and lipidic metabolism regulation and for the manufacture of a medicament for the treatment or prevention of diabetes and cardiovascular diseases. The acyclic sulfamide derivatives are also useful for cosmetic use.Type: ApplicationFiled: January 26, 2007Publication date: September 3, 2009Inventors: Fernando Antonio Rodriguez De Fonseca, Manuel Macias Gonzalez, Javier Pavon Moron, Maria Pilar Goya-Laza, Juan Antonio Paez Prosper, Carolina Cano Ramos